Market
StimCardio secures $30m in Series A round for wearable AF therapy
StimCardio Medical closed a $30m Series A funding round to advance Rhyvive, a non-invasive wearable device for atrial fibrillation therapy. The round was oversubscribed, indicating investor confidence in the company's development of an alternative to conventional AF treatments.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network